2014-10-16 |
1 |
|
'44 7
patent.
COUNT III: INFRINGEMENT OF U.S. PATENT NO. 7,598,271
43… OF INFRINGEMENT OF U.S. PATENT NO. 7,598,271
50. Paragraphs 1-49 are incorporated… action for patent infringement of U.S. Patent Nos. 5,874,447 (the
'"447 patent"), 7,598,271…7,598,271 (the '"271 patent"), and 8,658,663 (the "'663 patent") (collectively,
…,
the "patents-in-suit"), arising under the United States Patent Laws, Title 35, United States |
External link to document |
2016-11-20 |
180 |
|
assert four patents,
U.S. Patent Nos. 5,874,447 (the “447 patent”), 7,598,271 (the “271 patent), 8,658,…,663 (the “663
patent”), and 8,946,251 (the “251 patent”) (collectively, the “patents-in-suit”).
…disputed claim terms are found in the ‘271 patent and the ‘251 patent. They are:
• Crystalline…the patents-in-suit, as a drug for treating thermoregulatory dysfunction. See, e.g.,
‘251 Patent at …methanesulfonate. See, e.g., ‘447 patent 1:27-33.
Several of the patent claims at issue relate to different |
External link to document |
2016-11-20 |
181 |
|
language of U.S. Patent Nos. 7,598,271 (the "271 patent") and 8,946,251 (the 251 patent). Signed by Judge…
PACER Document
IN RE SEBELA PATENT LITIGATION
16 October 2014
14…14 September 2017
2:14-cv-06414
Patent
Defendant
District Court, D. New Jersey
|
External link to document |
2017-08-11 |
297 |
|
between the ’743 application and U.S. patent No. 6,063,927 (the “’927 patent”),
which was owned by SmithKline… (the “’663 patent”) and 8,946,251 (the “’251 patent”). A fourth patent,
U.S. Patent No. 5,874,447 (the…each of the patents in suit. SOF 1[ 15.
B. Patents in Suit
i. The ’271 Patent
The ’271 Patent, titled “…asserted three patents against Defendants: U.S. Patent Nos. 7,598,271 (the
“’271 patent”), 8,658,663 (…Defendants:
’271 patent: Claim l. SOF 11 32.
’663 patent: Claims 1, 2, and 5. SOF 11 41.
’251 patent: Claims 1 |
External link to document |